Linda Yoder - Academia.edu (original) (raw)

Papers by Linda Yoder

Journal of Wound Ostomy and Continence Nursing, Mar 1, 2005

Journal of Nursing Scholarship, Sep 1, 2008

Journal of Nursing Administration, Aug 17, 2023

Journal of Obstetric, Gynecologic, & Neonatal Nursing, May 1, 2010

Nursing Forum, 2012

The purpose of this paper is to provide a concept analysis of critical access health care. A comm... more The purpose of this paper is to provide a concept analysis of critical access health care. A common understanding of critical access health care would benefit those who legislate, provide, and consume health care. A review of the literature was conducted using an identical set of search terms that yielded a variety of sources; however, none were specifically related to critical access health care. No literature of concept analysis of critical access health care could be found. A concrete and measurable understanding of the concept will provide a common foundation to assist public and private entities in developing viable methods to understand healthcare policies, problems related to access, disparities in health care, and ways to increase health promotion and disease prevention.

PubMed, Jun 1, 2005

Note: This column is made possible through an educational grant from CChange, a Washington, DC, b... more Note: This column is made possible through an educational grant from CChange, a Washington, DC, based organization comprising the nation’s key cancer leaders from government, business, and nonprofit sectors. These cancer leaders share the vision of a future where cancer is prevented, detected early, and cured or is managed successfully as a chronic illness. The mission of C-Change is to leverage the combined expertise and resources of its members to eliminate cancer as a (major) public health problem at the earliest possible time. C-Change is both a forum and a catalyst for identifying issues and major challenges facing the cancer community and for initiating collaborative actions to complement the efforts of individual CChange members. Medical-Surgical nurses are invited to learn more about this important organization by visiting www.ndoc.org Linda H. Yoder

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, Apr 1, 2006

Note: This column and the complimentary Continuing Education credit are made possible through an ... more Note: This column and the complimentary Continuing Education credit are made possible through an educational grant from C-Change, a Washington, DC, based organization comprising the nation’s key cancer leaders from government, business, and nonprofit sectors. These cancer leaders share the vision of a future where cancer is prevented, detected early, and cured or is managed successfully as a chronic illness. The mission of C-Change is to leverage the combined expertise and resources of its members to eliminate cancer as a (major) public health problem at the earliest possible time. CChange is both a forum and a catalyst for identifying issues and major challenges facing the cancer community and for initiating collaborative actions to complement the efforts of individual C-Change members. Medical-Surgical nurses are invited to learn more about this important organization by visiting www.cchangetogether.org Linda H. Yoder

PubMed, Mar 14, 2012

Limited research exists comparing Vacutainer versus butterfly phlebotomy devices. The purpose of ... more Limited research exists comparing Vacutainer versus butterfly phlebotomy devices. The purpose of this study was to examine decision processes staff use when choosing a device. A qualitative, purposive sampling was used and determined a gap between correct device use and reported practice. Applied findings can enhance employee safety.

41st Biennial Convention (29 October - 2 November 2011), Oct 31, 2011

Sigma Theta Tau International's 24th International Nursing Research Congress, Jul 23, 2013

Methods: Seventy-eight participants were enrolled in this descriptive longitudinal study at the t... more Methods: Seventy-eight participants were enrolled in this descriptive longitudinal study at the time of discharge. Data were gathered at 5 time points: burn center discharge; 3, 6, 12, and 18 months postdischarge. The Burn Specific Health Scale-A (BSHS-A) and the Satisfaction with Life Scale were used; participants also completed demographic and clinical history forms. There were 14 attritions over 18 months due to participants’ relocation or the desire to no longer participate in the study. Data were analyzed using measures of central tendency, correlations, and one-way analysis of variance. The IRB approved this study.

PubMed, Aug 1, 2005

... Medical-surgical nurses are invited to learn more about this important organization by visiti... more ... Medical-surgical nurses are invited to learn more about this important organization by visiting www.ndoc.org Linda H. Yoder ... The incidence of melanoma has increased by 2,000% since 1930, and one person dies each hour from the disease (Poole & Guerry, 2005). More than ...

PubMed, Aug 1, 2007

This issue of the Cancer: Caring and Conquering column highlights ovarian cancer. The need for th... more This issue of the Cancer: Caring and Conquering column highlights ovarian cancer. The need for this column was brought to mind when a dear friend of mine died recently from ovarian cancer and it was clear that more information was needed concerning this insidious disease. Therefore, this column is d

PubMed, Feb 1, 2006

n the last several columns in this series, a basic overview of clinical trials was presented. In ... more n the last several columns in this series, a basic overview of clinical trials was presented. In this column, decision-making issues that patients and their fam- ily members or significant others may encounter as they confront the clinical trials process will be addressed. A person diagnosed with cancer must make many deci- sions, ranging from selecting physicians to choosing treatment options. Patients may feel over- whelmed and question their abili- ty to make sound decisions. Although timely treatment is important, patients should be en- couraged to take enough time to understand all available options in order to make informed decisions. Daugherty (2005) empha- sized that it is important to rec- ognize treatment decision making and information seeking as dis- tinctive and separate compo- nents of the medical encounter. He correctly refers to evidence suggesting that although patients generally express preferences for information about their illness and treatment, they might not engage in information-seeking behavior. Mansell, Poses, Kazis, and Duefield (2000) examined clinical factors that patients desire in order to participate in their treatment decisions. These researchers concluded that physicians should provide oppor- tunities for patient involvement in decisions about serious illness because patients want to be par- ticipants in those decisions. As the baby boomers continue to age, health care providers may see a change in information-seek- ing behavior as it relates to treat- ment decisions. More research is needed in this area. Clearly, patients, family mem- bers, and significant others must be advocates for the patient. Understanding initial treatment options can be confusing to the patient, but this situation can be compounded when an individual learns the cancer has recurred or a new malignancy is present. It is important to spend sufficient time with patients to ensure they understand various treatment options. In most cases, patients may require an additional appoint- ment to repeat the discussion because they may not have "heard" all the information at the time of diagnosis or during dis- cussion of relapse. For patients with cancer, treatment decisions are not a one-time experience. When one treatment is no longer effective, new options are pre- sented and more decisions must be made. Table 1 provides some tips that patients can use when discussing treatment options with their health care providers. Deciding to Enroll in Clinical Trials

PubMed, Aug 1, 2006

Patients with lung cancer can provide treatment challenges for even the most skilled clinician. M... more Patients with lung cancer can provide treatment challenges for even the most skilled clinician. More than 90% of adults with lung cancer are symptomatic when they are diagnosed. According to Van Cleave and Cooley (2004), a minority of patients present with local symptoms related to their primary tumor, but most present with either nonspecific systemic or metastatic symptoms (see Table 1). A new cough or a change in a chronic cough is often the presenting and most distressing symptom in people with lung cancer. Cough is present in 65%-75% of patients with lung cancer, and more than 25% have a productive cough. Many lung cancers occur in central airways and may lead to post-obstructive pneumonia; lymph node enlargement also may occur (Beckles, Spiro, Colice, & Rudd, 2003). Hemoptysis is the presenting symptom in 6%-35% of patients. Approximately 20%-30% of all patients will develop hemoptysis, with 3% experiencing fatal hemoptysis (Beckles et al., 2003; Knop, 2005; Van Cleave & Cooley, 2004). Dyspnea develops early in about 60% of patients, with approximately 65% of patients experiencing this distressing symptom during their illness. The causes of dyspnea in patients with lung cancer include tumor occlusion of a main airway or lung parenchyma, pleural effusion, pneumonia, and complications of chemotherapy or radiation therapy, such as pneumonitis (Beckles et al., 2003; Knop, 2005). The reported prevalence of pain in patients with lung cancer is 28%-51% (Gift, Jablonski, Stommel, & Given, 2004). Chest discomfort and/or chest wall pain is common and occurs in about 50% of patients at diagnosis. The discomfort is often ill-defined, aching, and intermittent. Pleuritic pain may be present due to direct spread of the tumor to the pleural surface (Beckles et al., 2003). Because the majority of patients with lung cancer present with advanced disease, lung cancer CE Objectives and Evaluation Form appear on page 235.

PubMed, Oct 1, 2006

Note: This column is made possible through an educational grant from C-Change, a Washington, DC, ... more Note: This column is made possible through an educational grant from C-Change, a Washington, DC, based organization comprising the nation’s key cancer leaders from government, business, and nonprofit sectors. These cancer leaders share the vision of a future where cancer is prevented, detected early, and cured or is managed successfully as a chronic illness. The mission of C-Change is to leverage the combined expertise and resources of its members to eliminate cancer as a (major) public health problem at the earliest possible time. C-Change is both a forum and a catalyst for identifying issues and major challenges facing the cancer community and for initiating collaborative actions to complement the efforts of individual C-Change members. Medical-Surgical nurses are invited to learn more about this important organization by visiting www.ndoc.org

PubMed, Apr 1, 1992

Cervical cancer is considered to be a preventable disease because of its lengthy preinvasive stat... more Cervical cancer is considered to be a preventable disease because of its lengthy preinvasive state, the effectiveness of screening programs, and the availability of effective treatment options for preinvasive lesions. Thus, identifying women with a greater probability of developing the disease is important to promoting early detection and instituting prompt treatment. Questions concerning risk factors that influence a woman's chances of developing cervical cancer are being addressed through research. Nurses who understand the epidemiology of cervical cancer and who are skilled in taking comprehensive health histories can play a major role in early detection and prompt treatment of cervical cancer by educating all women, including sexually active teenagers, about obtaining regular gynecologic screening exams.

Springer eBooks, Jun 14, 2018

MCN: The American Journal of Maternal/Child Nursing, 1997

PubMed, May 13, 2011

The Medical-Surgical Nursing Certification Board replicated a study to validate medical-surgical ... more The Medical-Surgical Nursing Certification Board replicated a study to validate medical-surgical nurses' perceptions, values, and behaviors related to specialty certification. Study results indicated both certified and non-certified medical-surgical nurses had positive perceptions of the value of certification.